Immune Checkpoint Inhibitors Market Size, Global Trends, Share

Research Methodology – Immune Checkpoint Inhibitors Market

At Straits Research, we adopt a rigorous 360° research approach that integrates both primary and secondary research methodologies. This ensures accuracy, reliability, and actionable insights for stakeholders. Our methodology for the Immune Checkpoint Inhibitors Market comprises the following key stages:

Market Indicator & Macro-Factor Analysis

Our baseline thesis for the Immune Checkpoint Inhibitors Market is developed by integrating key market indicators and macroeconomic variables. These include:

Factors considered while calculating market size and share

Prevalence and incidence rates of cancer globally
The number of FDA approved Immune Checkpoint Inhibitors
Market penetration of different Immune Checkpoint Inhibitors
Market share of the leading pharmaceutical companies manufacturing these inhibitors
Patent expiration dates of these inhibitors
Current and potential price of Immune Checkpoint Inhibitors
Research and development expenditure in the pharmaceutical sector
Government policies and regulations affecting the market
Healthcare expenditure per capita

Key Market Indicators

Total healthcare expenditure and as a percentage of GDP
Number of new cancer cases year-on-year
Growth of pharmaceutical industry
Research and Development spending in the pharmaceutical sector
Number of patents issued and expired in the field
Market shares of leading pharmaceutical companies producing Immune Checkpoint Inhibitors
Approval rates of new Immune Checkpoint Inhibitors
Growth in aging population a vulnerable segment

Growth Trends

Increasing prevalence of cancer globally
Rise in FDA approvals for Immune Checkpoint Inhibitors
Increasing investment in cancer research
Increase in strategic collaborations among pharmaceutical companies
Growing awareness and adoption of Immune Checkpoint Inhibitors
Rising trend of personalized medicine
Technological advancements facilitating the development of advanced Immune Checkpoint Inhibitors

Secondary Research

Our secondary research forms the foundation of market understanding and scope definition. We collect and analyze information from multiple reliable sources to map the overall ecosystem of the Immune Checkpoint Inhibitors Market. Key inputs include:

Company-Level Information

Annual reports, investor presentations, SEC filings
Company press releases and product launch announcements
Public executive interviews and earnings calls
Strategy briefings and M&A updates

Industry and Government Sources

Country-level industry associations and trade bodies
Government dossiers, policy frameworks, and official releases
Whitepapers, working papers, and public R&D initiatives
Relevant Associations for the Immune Checkpoint Inhibitors Market

Market Intelligence Sources

Broker reports and financial analyst coverage
Paid databases (Hoovers, Factiva, Refinitiv, Reuters, Statista, etc.)
Import/export trade data and tariff databases
Sector-specific journals, magazines, and news portals

Macro & Consumer Insights

Global macroeconomic indicators and their cascading effect on the industry
Demand–supply outlook and value chain analysis
Consumer behaviour, adoption rates, and commercialization trends

Primary Research

To validate and enrich our secondary findings, we conduct extensive primary research with industry stakeholders across the value chain. This ensures we capture both qualitative insights and quantitative validation. Our primary research includes:

Expert Insights & KOL Engagements

Key Opinion Leader (KOL) Engagements
Structured interviews with executives, product managers, and domain experts
Paid and barter-based interviews across manufacturers, distributors, and end-users

Focused Discussions & Panels

Discussions with stakeholders to validate demand-supply gaps
Group discussions on emerging technologies, regulatory shifts, and adoption barriers

Data Validation & Business POV

Cross-verification of market sizing and forecasts with industry insiders
Capturing business perspectives on growth opportunities and restraints

Data Triangulation & Forecasting

The final step of our research involves data triangulation ensuring accuracy through cross-verification of:

Demand-side analysis (consumption patterns, adoption trends, customer spending)
Supply-side analysis (production, capacity, distribution, and market availability)
Macroeconomic & microeconomic impact factors

Forecasting is carried out using proprietary models that combine: